(Q53571926)

15 May 2018

title

Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery. (English)

1 reference

15 May 2018

1 reference

1 reference

Yong Seok Lee

4

0 references

Yong Gyu Park

object named as

Yong Gyu Park

5

0 references

author name string

Jeong Hoon Bae

1

1 reference

15 May 2018

Joon Mo Lee

2

1 reference

15 May 2018

Ki Sung Ryu

3

1 reference

15 May 2018

Soo Young Hur

6

1 reference

15 May 2018

Woong Shik Ahn

7

1 reference

15 May 2018

Seong Eun Namkoong

8

1 reference

15 May 2018

language of work or name

English

0 references

publication date

26 April 2007

1 reference

15 May 2018

published in

Gynecologic Oncology

1 reference

15 May 2018

volume

106

1 reference

15 May 2018

issue

1

1 reference

15 May 2018

page(s)

193-200

1 reference

15 May 2018

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the G

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Intraperitoneal hyperthermic chemotherapy in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Intraperitoneal antineoplastic drug delivery: rationale and results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Thermal Enhancement of New Chemotherapeutic Agents at Moderate Hyperthermia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Hyperthermia and paclitaxel--epirubicin chemotherapy: enhanced cytotoxic effect in a murine mammary adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Intraoperative Chemotherapy for Peritoneal Carcinomatosis Arising From Colon Adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Hyperthermic potentiation.Biological aspects and applications to radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Intraperitoneal chemotherapy in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group tria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

The role of maintenance therapy and novel taxanes in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

Methodologic considerations in treatment using intraperitoneal chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.03.019

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2007.03.019

1 reference

15 May 2018

1 reference

15 May 2018